IBM Stock Before Q3 Earnings Release: To Buy or Not to Buy?
IBM Stock Before Q3 Earnings Release: To Buy or Not to Buy? Zacks Investment Research
Covered in this story
Analyst targets on IBM
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
- Barclays: $234 → $350 by Aug 2027 · Overweight via foreignpolicyjournal.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.